CombiGene AB (publ) (STO:COMBI)
2.420
+0.010 (0.41%)
Jun 24, 2025, 12:19 PM CET
CombiGene AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 73.75 | 101.44 | 131.78 | 136.74 | 48.9 | Upgrade
|
Cash & Short-Term Investments | 73.75 | 101.44 | 131.78 | 136.74 | 48.9 | Upgrade
|
Cash Growth | -27.30% | -23.02% | -3.63% | 179.67% | 222.40% | Upgrade
|
Accounts Receivable | - | - | 4.22 | - | 0.02 | Upgrade
|
Other Receivables | 0.87 | 1.21 | 2.59 | 7.46 | 0.94 | Upgrade
|
Receivables | 0.87 | 1.21 | 6.81 | 7.46 | 0.96 | Upgrade
|
Inventory | - | - | - | - | 0.82 | Upgrade
|
Prepaid Expenses | 0.5 | 0.59 | 0.59 | 0.39 | 4.65 | Upgrade
|
Other Current Assets | - | - | 0.04 | 0.02 | 0.04 | Upgrade
|
Total Current Assets | 75.12 | 103.24 | 139.22 | 144.62 | 55.37 | Upgrade
|
Property, Plant & Equipment | 0.67 | 0.85 | - | - | - | Upgrade
|
Long-Term Investments | 0 | 0 | - | - | - | Upgrade
|
Goodwill | - | 12.62 | 14.92 | 17.21 | 19.51 | Upgrade
|
Other Intangible Assets | - | 3.9 | 4.09 | 4.39 | 4.54 | Upgrade
|
Other Long-Term Assets | 0.08 | - | - | - | - | Upgrade
|
Total Assets | 75.88 | 120.61 | 158.22 | 166.22 | 79.41 | Upgrade
|
Accounts Payable | 0.51 | 0.8 | 1.79 | 3.38 | 3 | Upgrade
|
Accrued Expenses | 2.56 | 2.91 | 3.72 | 3.84 | 4.02 | Upgrade
|
Current Income Taxes Payable | - | - | 0.08 | 0.02 | 0.02 | Upgrade
|
Current Unearned Revenue | - | - | - | - | 0.68 | Upgrade
|
Other Current Liabilities | 1.23 | 0.45 | 0.51 | 0.7 | 0.26 | Upgrade
|
Total Current Liabilities | 4.3 | 4.16 | 6.1 | 7.94 | 7.98 | Upgrade
|
Total Liabilities | 4.3 | 4.16 | 6.1 | 7.94 | 7.98 | Upgrade
|
Common Stock | 0.99 | 0.99 | 0.99 | 0.99 | 22.93 | Upgrade
|
Additional Paid-In Capital | 224.12 | 224.12 | 224.12 | 224.12 | 136.3 | Upgrade
|
Retained Earnings | -153.54 | -108.66 | -72.99 | -66.83 | -87.8 | Upgrade
|
Total Common Equity | 71.58 | 116.46 | 152.12 | 158.28 | 71.43 | Upgrade
|
Shareholders' Equity | 71.58 | 116.46 | 152.12 | 158.28 | 71.43 | Upgrade
|
Total Liabilities & Equity | 75.88 | 120.61 | 158.22 | 166.22 | 79.41 | Upgrade
|
Net Cash (Debt) | 73.75 | 101.44 | 131.78 | 136.74 | 48.9 | Upgrade
|
Net Cash Growth | -27.30% | -23.02% | -3.63% | 179.67% | 498.77% | Upgrade
|
Net Cash Per Share | 3.72 | 5.12 | 6.66 | 7.90 | 5.47 | Upgrade
|
Filing Date Shares Outstanding | 19.8 | 19.8 | 19.8 | 19.8 | 11.46 | Upgrade
|
Total Common Shares Outstanding | 19.8 | 19.8 | 19.8 | 19.8 | 11.46 | Upgrade
|
Working Capital | 70.82 | 99.08 | 133.12 | 136.68 | 47.39 | Upgrade
|
Book Value Per Share | 3.61 | 5.88 | 7.68 | 7.99 | 6.23 | Upgrade
|
Tangible Book Value | 71.58 | 99.94 | 133.12 | 136.68 | 47.39 | Upgrade
|
Tangible Book Value Per Share | 3.61 | 5.05 | 6.72 | 6.90 | 4.13 | Upgrade
|
Machinery | 0.88 | 0.88 | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.